Correlation Between Summit Therapeutics and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Summit Therapeutics and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and Catalyst Pharmaceuticals.
Diversification Opportunities for Summit Therapeutics and Catalyst Pharmaceuticals
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Summit and Catalyst is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Summit Therapeutics and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Summit Therapeutics PLC is expected to generate 8.35 times more return on investment than Catalyst Pharmaceuticals. However, Summit Therapeutics is 8.35 times more volatile than Catalyst Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.09 per unit of risk. If you would invest 366.00 in Summit Therapeutics PLC on October 12, 2024 and sell it today you would earn a total of 1,516 from holding Summit Therapeutics PLC or generate 414.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.47% |
| Values | Daily Returns |
Summit Therapeutics PLC vs. Catalyst Pharmaceuticals
Performance |
| Timeline |
| Summit Therapeutics PLC |
| Catalyst Pharmaceuticals |
Summit Therapeutics and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Summit Therapeutics and Catalyst Pharmaceuticals
The main advantage of trading using opposite Summit Therapeutics and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.| Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
| Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |